LONDON, July 17, 2017 /PRNewswire/ -- Report Details
The pharmaceutical contract manufacturing market is expected to grow at a CAGR of 6.4% in the first half of the forecast period and CAGR of 5.7% in the second half of the forecast period. The market is estimated at $88bn in 2021 and $124bn in 2027.
Download the full report: https://www.reportbuyer.com/product/4810650/
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 235-page report you will receive 82 tables and 61 figures– all unavailable elsewhere.
The 235-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
- Global Pharmaceutical Contract Manufacturing Market forecasts from 2017-2027
Submarket forecasts at world level, from 2017-2027:
- Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products
- Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types
- Other applications of outsourced production - other related services
Revenue forecasts from 2017-2027, for 12 countries:
- United States (US)
- EU5: Germany, France, the UK, Italy and Spain
- BRIC: Brazil, Russia, India and China
- South Korea
- Japan
- Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry
- Qualitative Analysis from a CMO Perspective 2016-2027
- Qualitative Analysis from a Client Perspective 2016-2027
Visiongain's study is intended for anyone requiring commercial analyses for the Pharmaceutical Contract Manufacturing Market. You find data, trends and predictions.
Buy our report today Pharmaceutical Contract Manufacturing Market 2017-2027: Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages.
Download the full report: https://www.reportbuyer.com/product/4810650/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article